R&D Expense Growth
17.28%
Fiscal year · Period ending:

GLAXF R&D Expense Growth
What is r&d expense growth?
Year-over-year research & development expense growth.
GLAXF r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 17.2752% | |
| 2.8604% | |
| 13.3929% | |
| 3.9788% | |
| 10.1189% | |
| 4.9256% | |
| 17.3388% | |
| -13.025% | |
| 23.3738% | |
| 1.9101% | |
| 3.1884% | |
| -12.0571% | |
| 11.1681% | |
| -4.4572% | |
| -15.1742% | |
| 9.1206% | |
| 34.8478% | |
| -9.1697% | |
| -7.4779% | |
| 12.2819% | |
| 7.989% | |
| 4.0487% | |
| -3.7586% | |
| 13.2413% | |
| 1.3818% | |
| 99.0544% | |
| 9.1144% | |
| 1.3066% | |
| -1.1197% | |
| -24.6104% | |
| 79.4872% | |
| 16.1028% | |
| 24.2017% | |
| 25.2632% | |
| 13.0952% | |
| 30.031% | |
| 40.4348% | |
| 54.3624% | |
| 31.8584% | |
| 0% |
Frequently asked questions: GLAXF r&d expense growth
What is GSK plc (GLAXF)'s current r&d expense growth?
GSK plc (GLAXF)'s latest reported r&d expense growth (Fiscal year) is 17.28% as of Dec 31, 2025. Year-over-year research & development expense growth.
How much historical r&d expense growth data is available for GLAXF?
Stock Alarm Pro provides 40 dated annual fiscal periods observations for GSK plc (GLAXF)'s r&d expense growth, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.
How can I compare GLAXF's r&d expense growth to peers or set an alert?
You can open GLAXF's r&d expense growth in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on GLAXF delivered by push, email, or phone call.
Explore More
Explore 130+ historical metrics & ratios
Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance